[ad_1]
A pharmaceutical company organized a training session to inform the media about the latest developments in leukemia and its advanced treatments.
The session was chaired by the Professor of Hematology and Immunology of the Faculty of Medicine,] Power of the CML .
During the session, the company announced the launch of a training campaign under the slogan " Oncology On Air ", which includes a series of educational sessions to inform the media of scientific advances and available solutions. In collaboration with media experts such as the American University of America and Reuters.
The company decided to launch an awareness campaign on leukemia, As leukemia is the LMC In the last 50 years, a medical breakthrough has made an incurable disease only a bone marrow transplant a disease that can be cured by targeted therapies, which represents a breakthrough in the treatment of tumors in general. (19659002) The most important feature of this disease is that it results from a change in a single gene BCR-ABL making the function of targeted drugs easy, targeting a single gene, Unlike many other diseases that result from a change in more than one gene, limiting cure rates.
Studies have shown that targeted drugs will improve up to 90% patient survival rate and will rapidly improve follow-up and continuation of treatment without having to enter the hospital and transform the disease into chronic illness after a serious illness and allow the patient to exercise his normal life.
This series of sessions will include several trainings to inform journalists of the latest technological means to cope with the rapid development of the media sector, with the participation of the most important specialized entities such as the American University of Cairo and the 39 Reuters news agency. The company added that the first session of the campaign will address leukemia disease and its latest treatments, in the presence of many blood specialists and consultants in Egypt, as well as patient support organizations. , In collaboration with lecturers from the American University, as well as an educational seminar on bad cancer.
[ad_2]
Source link
